Navigation Links
Medications to Prevent Relapse to Cocaine Use

Treatment of cocaine addiction has always been hampered by high rates of relapse, even after prolonged drug abstinence. Research teams from the Drug Abuse Program of the VU Medical Center in the Netherlands and the intramural laboratories of the National Institute on Drug Abuse (NIDA) have identified a process in the brain that may lead to a new generation of medications to prevent relapse to cocaine use. //

In studies using rats, the scientists, led by Dr. Taco J. De Vries of VU Medical Center and Dr. Yavin Shaham of National Institute on Drug Abuse (NIDA), found that the same system — the cannabinoid system — that governs the pharmacological actions of marijuana in the brain also plays an important role in the neuronal processes underlying relapse to cocaine use. By blocking cannabinoid receptor activity with chemical antagonists, the investigators prevented relapse to cocaine use induced by exposure to cocaine-associated cues or by cocaine itself.

This finding could open up a new avenue for the development of drugs to prevent relapse to cocaine use induced by environmental cues. Treatment of cocaine addiction has always been hampered by high rates of relapse, even after prolonged drug abstinence, and this research could be the first step in the development of a new medicinal approach to make it easier for a recovering addict to remain drug-free.

'"/>




Page: 1

Related medicine news :

1. What happens when Medications go wrong?
2. More Elderly Take Inappropriate and Harmful Medications
3. Medications for depression
4. Medications linked to xerostomia and caries
5. Analyzing The Side Effects Of Some Common Medications
6. The Risks Involved In Purchase Of Over The Counter Medications
7. Trust In Doctors Can Affect Taking Medications
8. Medications Detected In Recycled Water In Los Angeles
9. Children Being Given "Adult" Medications, Report Says
10. Kidney Transplant Recipients Tardy In Taking Vital Medications
11. Stimulant Medications More Effective In Treating ADHD Than Nonstimulants
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/6/2016)... ... May 06, 2016 , ... Kenneth Cochran, DSc, RN, FACHE, ... of the South announced today that Dr. Robert Menuet, Interventional Cardiologist with Cardiovascular ... Ultrasound Guided Coronary Atherectomy. , This procedure involves the removal of ...
(Date:5/5/2016)... CA (PRWEB) , ... May 05, 2016 , ... TransWipe ... Final Cut Pro X. Drag and drop a TransWipe preset between two video clips ... from smooth corner wipes to colored panels with customizable color and orientation options. TransWipe ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... (LAIs), today announced a development collaboration with the Australian critical medicine company, ... disorders such as schizophrenia. , LAI medicines can offer improved therapeutic benefits over ...
(Date:5/5/2016)... ... May 05, 2016 , ... Einstein Medical is proud to announce ... latest news and commentary at the 2016 ASCRS/ASOA Symposium and Congress, which takes place ... of Cataract and Refractive Surgery and the American Society of Ophthalmic Administrations will be ...
(Date:5/5/2016)... ... ... Friday, May 6 - Sunday, May 8, fifteen elite athletes from Team Semper Fi ... Bike Camp, hosted in conjunction with WTB and Cannondale in Novato, ... share pro tips with the injured veterans as they rip down some of the best ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... , May 5, 2016 ... of the  "Europe Systemic Lupus Erythematosus Market ... to their offering.       (Logo: ... latest research Europe Systemic Lupus Erythematosus Market ... comprehensive insights into Systemic Lupus Erythematosus pipeline ...
(Date:5/4/2016)... 2016  It,s time for an upgrade. There are many medical recorders on the ... LCD, the illustrious DVMAXX HD  offers unparalleled connectivity and functionality.  Ampronix  is a ... class manufacturer of innovative technology.  Photo - http://photos.prnewswire.com/prnh/20160503/363416 ... ... ...
(Date:5/4/2016)... Yissum Research Development Company of the ... had signed an exclusive world-wide licensing and research agreement ... degradation and immunomodulatory drugs for cancer and immune dysfunction, ... first-in-class therapy for hematologic and solid malignancies. Financial terms ... novel technology was developed by Yinon Ben-Neriah , ...
Breaking Medicine Technology: